comparemela.com
Home
Live Updates
MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting : comparemela.com
MaaT Pharma Presents the Results of its Annual Ordinary and Extraordinary General Meeting
Regulatory News: MaaT Pharma (EURONEXT: MAAT the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing
Related Keywords
Karim Dabbagh ,
Jean Marie Lefebvre ,
Jean Volatier ,
Bpifrance Investissement ,
Nadia Kamal ,
Kepler Cheuvreux ,
Claude Bertrand ,
Senior Pr Corporate Communications ,
Company Universal Registration Document ,
Trophic Communications ,
Regulatory News ,
Microbiome Ecosystem ,
Extraordinary General Meeting ,
Seventure Partners ,
Chief Executive Officer ,
Annual General Meeting ,
Universal Registration ,
General Meeting ,
Maat Pharma ,
Microbiome Ecosystem Therapies ,
Euronext Paris ,
Investor Relations ,
Communications Manager ,
Ihr Portfolio ,
comparemela.com © 2020. All Rights Reserved.